A detailed history of Proffitt & Goodson Inc transactions in Amgen Inc stock. As of the latest transaction made, Proffitt & Goodson Inc holds 80 shares of AMGN stock, worth $25,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Holding current value
$25,272
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$268.87 - $324.56 $21,509 - $25,964
80 New
80 $22,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Proffitt & Goodson Inc Portfolio

Follow Proffitt & Goodson Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proffitt & Goodson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Proffitt & Goodson Inc with notifications on news.